No Data
No Data
Wuhan Keqian Biology Co., Ltd. (688526.SH) has repurchased 0.4084% of its shares.
On July 31st, Gelonhui reported that Wuhan Keqian Biology Co., Ltd. (688526.SH) has cumulatively repurchased 1,903,866 shares of the company's stock through the Shanghai Stock Exchange trading system by centralized bidding trading method as of July 31, 2024, accounting for 0.4084% of the company's total share capital of 466,128,056 shares. The highest transaction price for the repurchase was 18.90 yuan/share, the lowest price was 13.48 yuan/share, and the total amount paid was RMB 31,618,428.15 (excluding stamp duty, transaction fees, and other trading expenses).
Wuhan Keqian Biology Co., Ltd. (688526.SH): Has repurchased 0.3828% of the company's shares.
On July 1st, Gelonhui reported that Wuhan Keqian Biology Co.,Ltd. (688526.SH) has accumulated repurchased 1,784,466 company shares through Shanghai Stock Exchange trading system by centralized bidding trading method until June 30, 2024. The repurchased shares account for 0.3828% of the company's total share capital of 466,168,016 shares. The highest and lowest repurchase prices were 18.90 yuan/share and 16.22 yuan/share respectively. The total amount of funds paid was approximately RMB 30,003,615.69 yuan (excluding stamp duty, trading commission and other transaction costs).
Wuhan Keqian Biology Co.,Ltd (688526.SH): Shareholder and supervisor Ye Changfa plan to reduce their shareholding by no more than 1.48%.
On June 14, Gelunhui reported that Wuhan Keqian Biology Co., Ltd. (stock code 688526.SH) announced that due to its own capital needs, Mr. Ye Changfa, a shareholder and supervisor holding more than 5% of the company's shares, plans to reduce his share through a combination of centralized bidding and bulk trade, with a total reduction of no more than 6,876,535 shares, or no more than 1.48% of the total share capital of the company, and the proportion of the total number of shares held by the individual shareholder before the shareholding reduction does not exceed 25%. Among them, the number of shares to be reduced through centralized bidding does not exceed 4,661,680 shares, accounting for no more than 1.00% of the total share capital of the company, and the shares will be reduced within any consecutive 90 natural days.
Keqian Biotech (688526.SH): A total cost of 30.36 million yuan to buy back 0.3828% of the shares
Gelonghui, May 31 | Keqian Biotech (688526.SH) announced that as of May 31, 2024, the company had repurchased a total of 1,784,466 shares of the company through centralized bidding transactions, accounting for 0.3828% of the company's total share capital of 466,168,016 shares. The highest price for the repurchase transaction was 18.90 yuan/share, the lowest price was 16.22 yuan/share, and the total amount of capital paid was RMB 30,003,615.69 (excluding transaction fees such as tax and transaction fees).
Ke Qian Biology (688526.SH): Plans to use the raised capital of 287 million yuan for the new project “High-Level Animal Vaccine Industrialization Base Construction Project (Phase I)”
Gelonghui, May 20 | Keqian Biology (688526.SH) announced that the company plans to use the capital raised from the initial fund-raising project “Animal Biological Products Workshop Technical Improvement Project” of 287 million yuan (the actual amount is subject to the balance of the special account raised after review and approval by the shareholders' meeting) for the new project “High-Level Animal Vaccine Industrialization Base Construction Project (Phase 1)”. The total planned investment amount for the new project is about RMB 600 million (the final total investment amount is based on actual investment).
Keqian Biotech (688526.SH) will distribute 4.3 yuan for every 10 shares in 2023. The stock registration date is May 21
Keqian Biotech (688526.SH) announced that the company will implement the 2023 annual equity distribution, for every 10 shares...
No Data